The Mark Foundation for Cancer Research ASPIRE Awards (Accelerating Scientific Platforms and Innovative Research) support innovative ideas that have the potential to solve high-impact problems in cancer research, but may not have extensive – or any – preliminary supporting data.
ASPIRE Awards enable high-risk, high-reward projects to answer key feasibility and proof-of-concept questions and arrive at critical project inflection points in an accelerated time frame. ASPIRE Awards support work from bench to bedside, and special consideration is given to previously unaddressed questions and challenging concepts. The scope of ASPIRE Awards includes:
- Basic Research: Projects that have the potential to substantially accelerate understanding of cancer disease mechanisms and pathophysiology
- Therapeutic Discovery and Translational Science: Projects that include initial investigations of novel concepts in cancer therapeutics and/or that seek to answer key translational science questions on the critical path to the clinic
- Innovative Technologies: Projects aimed at developing innovative technology solutions that are integrated with leading-edge concepts in cancer biology
- Clinical Research: Projects involving biomarker-rich, early-stage clinical trials and correlative studies that address fundamental questions related to the interplay of cancer therapy, intervention and/or companion diagnostics and biology
Please refer to the bottom of this page to explore current and former ASPIRE awards.